Umbelliferone attenuates cisplatin‐induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2
Physiological Reports · 2023
DOI: 10.14814/phy2.15879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Zhenle Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong).
Abstract (Originalsprache)
In this study, we investigated the nephroprotective effects of Umbelliferone (UMB) against cisplatin‐induced acute kidney injury (AKI). C57BL/6J mice were treated with cisplatin via a single intraperitoneal injection (25 mg/kg) with or without UMB (40 mg/kg/day) by gavage. Renal function, apoptosis, oxidative stress, inflammation, and mitochondrial function were analyzed to evaluate kidney injury. In vitro, human proximal tubule epithelial cells were treated with cisplatin, with or without UMB, for 24 h. Western blotting and immunohistochemistry were performed to explore the mechanisms underlying the nephroprotective effects of UMB. Cisplatin‐induced renal dysfunction, including increases in blood urea nitrogen, serum creatinine, and renal tubular injury indices (NGAL and KIM‐1), were significantly attenuated by UMB treatment, along with renal phenotypic changes and renal tubular injury, as evidenced by improved renal histology. Moreover, NRF2 was activated by UMB pretreatment, along with the inhibition of oxidative stress and inflammatory response, as evidenced by decreased levels of antioxidant genes and inflammatory cytokines in cisplatin‐induced AKI. Our results demonstrate that UMB can protect against cisplatin‐induced nephrotoxicity, which is mediated by the NRF2 signaling pathway via antioxidant and anti‐inflammatory activities, suggesting the clinical potential of UMB for the treatment of AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Pediatrics, Shandong University, Shandong Provincial Hospital, Jinan, Shandong, China.
ORCID-Profile: Suwen Liu
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong)
Zitieren
APA
Yang, Z., Ning, R., Liu, Q., Zang, R., Liu, S., & Sun, S. (2023). Umbelliferone attenuates cisplatin‐induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2. Physiological Reports. https://doi.org/10.14814/phy2.15879
Vancouver
Yang Z, Ning R, Liu Q, Zang R, Liu S, Sun S. Umbelliferone attenuates cisplatin‐induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2. Physiological Reports. 2023. doi:10.14814/phy2.15879
BibTeX
@article{Yang2023,
author = {Yang, Zhenle and Ning, Ruofei and Liu, Qianying and Zang, Ruixian and Liu, Suwen and Sun, Shuzhen},
title = {Umbelliferone attenuates cisplatin‐induced acute kidney injury by inhibiting oxidative stress and inflammation via NRF2},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15879}
}
EUVIMED